Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COBRA treatment strategies in early rheumatoid arthritis
2008-007225-39Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Feb 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of methotrexate, 5-aminosalicylic acid + sulphasalazine, leflunomide and prednisolone in rheumatoid arthritis (RA) (4 arms), sponsored by UZ Leuven. Primary endpoint: Proportion in remission. Started Feb 2009; status: completed.
02
Drugs
methotrexate5-aminosalicylic acid + sulphasalazineleflunomideprednisolone
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2008-007225-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007225-39.